Palvella Therapeutics Inc
(PVLA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 18,474 | 3,762 | N/A | N/A |
| Receivables | N/A | 548 | N/A | N/A |
| Other current assets | 0 | 450 | 0 | 0 |
| TOTAL | $19,805 | $4,820 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 2,052 | 2,438 | N/A | N/A |
| Other Non-Current Assets | 0 | 19 | 0 | 0 |
| TOTAL | $2,052 | $2,457 | $N/A | $N/A |
| Total Assets | $21,858 | $7,277 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 1,271 | 207 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,260 | 278 | 0 | 0 |
| Accrued Expenses | 987 | 560 | N/A | N/A |
| Other current liabilities | N/A | 161 | N/A | N/A |
| TOTAL | $3,517 | $1,768 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | N/A | 1,445 | N/A | N/A |
| Deferred Revenues | N/A | 545 | N/A | N/A |
| Other Non-Current Liabilities | 334 | 3,479 | 0 | 0 |
| TOTAL | $334 | $4,924 | $N/A | $N/A |
| Total Liabilities | $3,851 | $6,692 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 29 | 12 | N/A | N/A |
| Retained earnings | -65,807 | -55,957 | N/A | N/A |
| Other shareholders' equity | -843 | -1,078 | 0 | 0 |
| TOTAL | $18,006 | $585 | $N/A | $N/A |
| Total Liabilities And Equity | $21,858 | $7,277 | $0 | $0 |